- 专利标题: C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
-
申请号: US16071925申请日: 2017-02-02
-
公开(公告)号: US20190031709A1公开(公告)日: 2019-01-31
- 发明人: Jie CHEN , Yan CHEN , Ira B. DICKER , Richard A. HARTZ , Nicholas A. MEANWELL , Beata NOWICKA-SANS , Alicia REGUEIRO-REN , Sing-Yuen SIT , Ny SIN , Jacob SWIDORSKI , Brian Lee VENABLES
- 申请人: ViiV HEALTHCARE UK (NO.5) LIMITED
- 国际申请: PCT/IB2017/050568 WO 20170202
- 主分类号: C07J53/00
- IPC分类号: C07J53/00 ; A61P31/18
摘要:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
公开/授权文献
- US10421774B2 C-3 and C-17 modified triterpenoids as HIV-1 inhibitors 公开/授权日:2019-09-24
信息查询